On Wednesday, March 4, 2015, the Vaccines and Related Biological Products Advisory Committee (VRBPAC) made recommendations on the selection of strains to be included in the influenza virus vaccine for the 2015 to 2016 influenza season in the U.S. Members agreed almost unanimously with the World Health Organization (WHO) strain recommendations.
Back to All Events
Earlier Event: March 4
Science Board to the FDA (SBFDA)
Later Event: March 9
Dermatologic and Ophthalmic Drugs Advisory Committee Meeting